Publications

Read more about the thinking that enables Syntel to deliver value to our clients.

Digital Services

Transform Labeling and Packaging with Next-Generation Automated Services from Syntel

Life Sciences companies face many challenges delivering product labels tailored to every global market where they compete.

Syntel’s Prescription for Automating Pharmacovigilance Adverse Events Management

It’s no secret that drug and device safety is of the utmost importance in today’s competitive life sciences marketplace, and pharmacovigilance (PV) is a major component of an effective drug regulation system for evaluating and monitoring adverse events (AEs).

A New Prescription for Regulatory Compliance:Syntel’s Intelligent Regulatory Services Platform

Global life sciences companies are facing exceptional business pressure. In today’s evolving regulatory environment, new directives and regulations increasingly pose not just a long term need, but a real-time operational challenge as well.

Evolving to Next Generation Clinical Data Management Services

With 40% of drugs going off patent in the near future, increasing demand for accessible healthcare and a patient-centric approach, and pressure on the payer sector, the life sciences industry today demands innovation and excellence in order to succeed.

Optimize Performance by Harmonizing Computer System Validation

Computer system validation (CSV) is an integral process for pharmaceutical, biotech and medical device companies.

Centralized Global Partner to Support Scalable Model for Future Generation e-DMS

Dealing with multiple Document Management Systems (DMS) across multiple teams around the globe is a challenge for the Pharmaceutical industry. In order to realize tangible benefits from

Smoothing the Transition to EU MDR

The Medical Device sector is undergoing a series of unprecedented regulatory changes, affecting functions all the way from product design to market surveillance.

Leading Digital Modernization in Life Sciences Companies: A Syntel Brief

The Life Sciences industry has entered a new era with increasing competitive pressures, a rapidly evolving healthcare landscape, disruptive digital technology changes, and deeper regulatory scrutiny.

Operational Model for Pharmacovigilance

Global Health Regulatory Agencies mandate all Pharmaceutical and Modern Drug Discovery companies to collect, process, and report adverse events. Organizations failing to achieve 100% compliance may face penalties or face drug withdrawal from the market.

Syntel’s Trial Master File Management

It is imperative and crucial for organizations to produce requested clinical records on time for various inspections and audits. Life sciences, medical devices and contract research organizations find it difficult and time consuming to cater such requirements.